Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Orlando, Florida 32809


Purpose:

To evaluate safety and compare the pharmacokinetic parameters from the fixed dose combination ABT-143 relative to that from the co-administration of the two monotherapies.


Criteria:

Inclusion Criteria: - General good health - BMI 19 to 29 Exclusion Criteria: - Currently enrolled in another study - Females who are pregnant or breastfeeding


NCT ID:

NCT00681395


Primary Contact:

Study Director
Torbjörn Lundström, MD
AstraZeneca


Backup Contact:

N/A


Location Contact:

Orlando, Florida 32809
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 23, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.